This review (2021) summarizes the current state of research regarding the use of ketamine and esketamine for depression. Across 11 studies it was found that ketamine alleviated symptoms of depression 40 min to 1 week while esketamine improved symptoms at 2 hours to 4 weeks. The methodological quality of most reviews was described as critically low.
- Published
- Journal
- European Journal of Clinical Pharmacology
- Authors
- de Mendoça Lima, T., Visacri, M. B., Aguiar, P. M.